Down-regulation of neogenin accelerated glioma progression through promoter methylation and its overexpression in SHG-44 induced apoptosis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Wu, Xinmin ^a,b   Li, Yunqian ^b   Wan, Xilin ^a   Kayira, Tabitha Mlowoka ^a   Cao, Rangjuan ^a   Ju, Xingda ^a   Zhu, Xiaojuan ^a   Zhao, Gang ^b  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEOGENIN; MEMBRANE PROTEIN;

ADULT; ADVANCED CANCER; APOPTOSIS; ARTICLE; BRAIN TISSUE; CANCER GRADING; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TISSUE LEVEL; TUMOR GROWTH; TUMOR RECURRENCE; WESTERN BLOTTING; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TUMOR CELL LINE;

ADULT; APOPTOSIS; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECURRENCE;

EID: 84861562192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038074     Document Type: Article

References (58)

1. Paunu N, Pukkala E, Laippala P, Sankila R, Isola J, et al. (2002) Cancer incidence in families with multiple glioma patients. Int J Cancer 97: 819-822.
2. The Surveillance, Epidemiology and End Results website. 1 Available: http://seer.cancer.gov/statfacts/html/brain.html. Accessed 2011 November.
3. Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
4. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
5. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, et al. (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113: 1953-1968.
6. Fitzgerald DP, Bradford D, Cooper HM, (2007) Neogenin is expressed on neurogenic and gliogenic progenitors in the embryonic and adult central nervous system. Gene Expr Patterns 7: 784-792.
7. Yamashita T, Mueller BK, Hata K, (2007) Neogenin and repulsive guidance molecule signaling in the central nervous system. Curr Opin Neurobiol 17: 29-34.
8. Matsunaga E, Chédotal A, (2004) Repulsive guidance molecule/neogenin: a novel ligand-receptor system playing multiple roles in neural development. Dev Growth Differ 46: 481-486.
9. Vielmetter J, Kayyem J, Roman J, Dreyer W, (1994) Neogenin, an avian cell surface protein expressed during terminal neuronal differentiation, is closely related to the human tumor suppressor molecule deleted in colorectal cancer. J Cell Biol 127: 2009-2020.
10. Lejmi E, Leconte L, Pedron-Mazoyer S, Ropert S, Raoul W, et al. (2008) Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B. Proc Natl Acad Sci U S A 105: 12491-12496.
11. Cole SJ, Bradford D, Cooper HM, (2007) Neogenin: A multi-functional receptor regulating diverse developmental processes. Int J Biochem Cell Biol 39: 1569-1575.
12. Wilson NH, Key B, (2007) Neogenin: one receptor, many functions. Int J Biochem Cell Biol 39: 874-878.
13. Wilson NH, Key B, (2006) Neogenin interacts with RGMa and netrin-1 to guide axons within the embryonic vertebrate forebrain. Dev Biol 296: 485-498.
14. Matsunaga E, Nakamura H, Chedotal A, (2006) Repulsive guidance molecule plays multiple roles in neuronal differentiation and axon guidance. J Neurosci 26: 6082-6088.
15. Yang F, APW Jr, Bjorkman PJ, (2011) Crystal structure of a hemojuvelin-binding fragment of neogenin at 1.8A. J Struct Biol 174: 239-244.
16. Fujita Y, Taniguchi J, Uchikawa M, Endo M, Hata K, et al. (2008) Neogenin regulates neuronal survival through DAP kinase. Cell Death Differ 15: 1593-1608.
17. Mille F, Llambi F, Guix C, Delloye-Bourgeois C, Guenebeaud C, et al. (2009) Interfering with multimerization of netrin-1 receptors triggers tumor cell death. Cell Death Differ 16: 1344-1351.
18. Shin GJ, Wilson NH, (2008) Overexpression of repulsive guidance molecule (RGM) a induces cell death through Neogenin in early vertebrate development. J Mol Histol 39: 105-113.
19. Matsunaga E, Tauszig-Delamasure S, Monnier PP, Mueller BK, Strittmatter SM, et al. (2004) RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol 6: 749-755.
20. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, et al. (2004) Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431: 76-80.
21. Arakawa H, (2004) Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 4: 978-987.
22. Arakawa H, (2005) p53, apoptosis and axon-guidance molecules. Cell Death Differ 12: 1057-1065.
23. Rodrigues S, De Wever O, Bruyneel E, Rooney RJ, Gespach C, (2007) Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 26: 5615-5625.
24. Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, et al. (2003) The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci U S A 100: 4173-4178.
25. Mehlen P, Thibert C, (2004) Dependence receptors: between life and death. Cell Mol Life Sci 61: 1854-1866.
26. Lee H, Seo I, Shin Y, Lee S, Seo S, et al. (2008) Netrin-1 specifically enhances cell spreading on fibronectin in human glioblastoma cells. Korean J Physiol Pharmacol 12: 225-230.
27. Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helie M, et al. (1997) Loss of DCC expression and glioma progression. Cancer Res 57: 382-386.
28. Jarjour AA, Durko M, Luk TL, Marcal N, Shekarabi M, et al. (2011) Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation. PLoS One 6: e25408.
29. Papanastasiou AD, Pampalakis G, Katsaros D, S G, (2011) Netrin-1 overexpression is predictive of ovarian malignancies. Oncotarget 2: 363-367.
30. Lee JE, Kim HJ, Bae JY, Kim SW, Park JS, et al. (2005) Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer. BMC Cancer 5: 154.
31. Berrar D, Sturgeon B, Bradbury I, Downes C, Dubitzky W, (2005) Survival trees for analyzing clinical outcome in lung adenocarcinomas based on gene expression profiles: identification of neogenin and diacylglycerol kinase alpha expression as critical factors. J Comput Biol 12: 534-544.
32. Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, et al. (2011) Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene 30: 1402-1412.
33. Tran T, Barlow B, O'Rear L, Jarvis B, Li Z, et al. (2011) Loss of the alpha2beta1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro. PLoS One 6: e26858.
34. Bernet A, Mazelin L, Coissieux M, Gadot N, Ackerman S, et al. (2007) Inactivation of the UNC5C netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 133: 1840-1848.
35. Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, et al. (2011) DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 103: 143-153.
36. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
37. Meyerhardt JA, Look AT, Bigner SH, Fearon ER, (1997) Identification and characterization of neogenin, a DCC-related gene. Oncogene 14: 1129-1136.
38. Hanninen MM, Haapasalo J, Haapasalo H, Fleming RE, Britton RS, et al. (2009) Expression of iron-related genes in human brain and brain tumors. BMC Neurosci 10: 36.
39. Li VS, Yuen ST, Chan TL, Yan HH, Law WL, et al. (2009) Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. Gastroenterology 137: 176-187.
40. Latil A, Chene L, Cochant-Priollet B, Mangin P, Fournier G, et al. (2003) Quantification of expression of netrins, slits and their receptors in human prostate tumors. International Journal of Cancer 103: 306-315.
41. Grady W, (2007) Making the Case for DCC and UNC5C as Tumor-Suppressor Genes in the Colon. Gastroenterology 133: 2045-2049.
42. Mehlen P, Rabizadeh S, Snipas S, Assa-Munt N, Salvesen G, et al. (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395: 801-804.
43. Nakatani K, Yoshimi N, Mori H, Sakai H, Shinoda J, et al. (1998) The significance of the expression of tumor suppressor gene DCC in human gliomas. J Neurooncol 40: 237-242.
44. Hibi K, Sakata M, Sakuraba K, Kitamura Y, Shirahata A, et al. (2010) Methylation of the DCC Gene Is Lost in Advanced Gastric Cancer. Anticancer Res 30: 107-109.
45. Hibi K, Mizukami H, Shirahata A, Goto T, Sakata M, et al. (2009) Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer. World J Surg 33: 1053-1057.
46. Lin K, Taylor JR Jr, Wu TD, Gutierrez J, Elliott JM, et al. (2011) TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma. PLoS One 6: e18608.
47. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, et al. (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335: 1727-1732.
48. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, et al. (1994) The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes & Development 8: 1174-1183.
49. Nighat PK, AA Pandith, MUl Hussain, A Yousuf, MS Khan, et al. (2011) Loss of heterozygosity (LOH) of deleted in colorectal cancer (DCC) gene and predisposition to colorectal cancer: Significant association in colorectal cancer patients of Kashmir. Journal of Cancer Research and Experimental Oncology 3.
50. Mehlen P, Llambi F, (2005) Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers. Br J Cancer 93: 1-6.
51. Mehlen P, Guenebeaud C, (2010) Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol 22: 46-54.
52. Paradisi A, Maisse C, Coissieux MM, Gadot N, Lepinasse F, et al. (2009) Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci U S A 106: 17146-17151.
53. Fitamant J, Guenebeaud C, Coissieux MM, Guix C, Treilleux I, et al. (2008) Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci U S A 105: 4850-4855.
54. Delloye-Bourgeois C, Fitamant J, Paradisi A, Cappellen D, Douc-Rasy S, et al. (2009) Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med 206: 833-847.
55. Graf D, Bode JG, Haussinger D, (2007) Caspases and receptor cleavage. Arch Biochem Biophys 462: 162-170.
56. Mehlen P, Delloye-Bourgeois C, Chedotal A, (2011) Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat Rev Cancer 11: 188-197.
57. Eveno C, Broqueres-You D, Feron JG, Rampanou A, Tijeras-Raballand A, et al. (2011) Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesis. Am J Pathol 178: 1861-1869.
58. Herman J, Graff J, Myöhänen S, Nelkin B, Baylin S, (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-9826.